Consistent with these data, inhibition of LOX activity with βAPN in an invasive breast cancer model (MMTV-Neu mice) reduced collagen cross-linking, fibrillar collagen deposition, and the formation of high-grade lesions [146]. Here, LOX is linked to breast carcinoma.